J R Koethe1, C A Jenkins1, B Lau2, B E Shepherd1, M J Silverberg3, T T Brown2, A J Blashill4, A Anema5, A Willig6, S Stinnette7, S Napravnik7, J Gill8, H M Crane9, T R Sterling1. 1. Departments of Medicine and Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA. 2. Departments of Epidemiology and Medicine, Johns Hopkins University, Baltimore, MD, USA. 3. Kaiser Permanente Northern California, Oakland, CA, USA. 4. Harvard Medical School, Boston, MA, USA. 5. British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada. 6. University of Alabama at Birmingham, Birmingham, AL, USA. 7. University of North Carolina, Chapel Hill, NC, USA. 8. Alberta HIV Clinic, Sheldon M. Chumir Health Centre, Calgary, AB, Canada. 9. Center for AIDS Research, University of Washington, Seattle, WA, USA.
Abstract
OBJECTIVES: Adipose tissue affects several aspects of the cellular immune system, but prior epidemiological studies have differed on whether a higher body mass index (BMI) promotes CD4 T-cell recovery on antiretroviral therapy (ART). The objective of this analysis was to assess the relationship between BMI at ART initiation and early changes in CD4 T-cell count. METHODS: We used the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) data set to analyse the relationship between pre-treatment BMI and 12-month CD4 T-cell recovery among adults who started ART between 1998 and 2010 and maintained HIV-1 RNA levels < 400 copies/mL for at least 6 months. Multivariable regression models were adjusted for age, race, sex, baseline CD4 count and HIV RNA level, year of ART initiation, ART regimen and clinical site. RESULTS: A total of 8381 participants from 13 cohorts contributed data; 85% were male, 52% were nonwhite, 32% were overweight (BMI 25-29.9 kg/m(2) ) and 15% were obese (BMI > 30 kg/m(2) ). Pretreatment BMI was associated with 12-month CD4 T-cell change (P < 0.001), but the relationship was nonlinear (P < 0.001). Compared with a reference of 22 kg/m(2) , a BMI of 30 kg/m(2) was associated with a 36 cells/μL [95% confidence interval (CI) 14, 59 cells/μL] greater CD4 T-cell count recovery among women and a 19 cells/μL (95% CI 9, 30 cells/μL) greater recovery among men at 12 months. At a BMI > 30 kg/m(2) , the observed benefit was attenuated among men to a greater degree than among women, although this difference was not statistically significant. CONCLUSIONS: A BMI of approximately 30 kg/m(2) at ART initiation was associated with greater CD4 T-cell recovery at 12 months compared with higher or lower BMI values, suggesting that body composition may affect peripheral CD4 T-cell recovery.
OBJECTIVES: Adipose tissue affects several aspects of the cellular immune system, but prior epidemiological studies have differed on whether a higher body mass index (BMI) promotes CD4 T-cell recovery on antiretroviral therapy (ART). The objective of this analysis was to assess the relationship between BMI at ART initiation and early changes in CD4 T-cell count. METHODS: We used the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) data set to analyse the relationship between pre-treatment BMI and 12-month CD4 T-cell recovery among adults who started ART between 1998 and 2010 and maintained HIV-1 RNA levels < 400 copies/mL for at least 6 months. Multivariable regression models were adjusted for age, race, sex, baseline CD4 count and HIV RNA level, year of ART initiation, ART regimen and clinical site. RESULTS: A total of 8381 participants from 13 cohorts contributed data; 85% were male, 52% were nonwhite, 32% were overweight (BMI 25-29.9 kg/m(2) ) and 15% were obese (BMI > 30 kg/m(2) ). Pretreatment BMI was associated with 12-month CD4 T-cell change (P < 0.001), but the relationship was nonlinear (P < 0.001). Compared with a reference of 22 kg/m(2) , a BMI of 30 kg/m(2) was associated with a 36 cells/μL [95% confidence interval (CI) 14, 59 cells/μL] greater CD4 T-cell count recovery among women and a 19 cells/μL (95% CI 9, 30 cells/μL) greater recovery among men at 12 months. At a BMI > 30 kg/m(2) , the observed benefit was attenuated among men to a greater degree than among women, although this difference was not statistically significant. CONCLUSIONS: A BMI of approximately 30 kg/m(2) at ART initiation was associated with greater CD4 T-cell recovery at 12 months compared with higher or lower BMI values, suggesting that body composition may affect peripheral CD4 T-cell recovery.
Authors: Stephen J Gange; Mari M Kitahata; Michael S Saag; David R Bangsberg; Ronald J Bosch; John T Brooks; Liviana Calzavara; Steven G Deeks; Joseph J Eron; Kelly A Gebo; M John Gill; David W Haas; Robert S Hogg; Michael A Horberg; Lisa P Jacobson; Amy C Justice; Gregory D Kirk; Marina B Klein; Jeffrey N Martin; Rosemary G McKaig; Benigno Rodriguez; Sean B Rourke; Timothy R Sterling; Aimee M Freeman; Richard D Moore Journal: Int J Epidemiol Date: 2007-01-08 Impact factor: 7.196
Authors: Valerianna Amorosa; Marie Synnestvedt; Robert Gross; Harvey Friedman; Rob Roy MacGregor; Debie Gudonis; Ian Frank; Pablo Tebas Journal: J Acquir Immune Defic Syndr Date: 2005-08-15 Impact factor: 3.731
Authors: Nancy F Crum-Cianflone; Mollie Roediger; Lynn E Eberly; Kurt Vyas; Mike L Landrum; Anuradha Ganesan; Amy C Weintrob; Robert Vincent Barthel; Brian K Agan Journal: AIDS Date: 2010-04-24 Impact factor: 4.177
Authors: Elif Arioglu Oral; Edward D Javor; Li Ding; Gulbu Uzel; Elaine K Cochran; Janice Ryan Young; Alex M DePaoli; Steven M Holland; Phillip Gorden Journal: J Clin Endocrinol Metab Date: 2005-11-29 Impact factor: 5.958
Authors: Julie Womack; Phyllis C Tien; Joseph Feldman; Ja Hyun Shin; Kristopher Fennie; Kathryn Anastos; Mardge H Cohen; Melanie C Bacon; Howard Minkoff Journal: Metabolism Date: 2007-07 Impact factor: 8.694
Authors: Nancy Crum-Cianflone; Mollie Poehlman Roediger; Lynn Eberly; Maryam Headd; Vincent Marconi; Anuradha Ganesan; Amy Weintrob; R Vincent Barthel; Susan Fraser; Brian K Agan Journal: PLoS One Date: 2010-04-09 Impact factor: 3.240
Authors: Jason V Baker; Grace Peng; Joshua Rapkin; David Krason; Cavan Reilly; Winston P Cavert; Donald I Abrams; Rodger D MacArthur; Keith Henry; James D Neaton Journal: J Acquir Immune Defic Syndr Date: 2008-08-15 Impact factor: 3.731
Authors: I Sadaf Farooqi; Giuseppe Matarese; Graham M Lord; Julia M Keogh; Elizabeth Lawrence; Chizo Agwu; Veronica Sanna; Susan A Jebb; Francesco Perna; Silvia Fontana; Robert I Lechler; Alex M DePaoli; Stephen O'Rahilly Journal: J Clin Invest Date: 2002-10 Impact factor: 14.808
Authors: Kassem Bourgi; Peter F Rebeiro; Megan Turner; Jessica L Castilho; Todd Hulgan; Stephen P Raffanti; John R Koethe; Timothy R Sterling Journal: Clin Infect Dis Date: 2020-03-17 Impact factor: 9.079
Authors: Barbara S Taylor; Kaku So-Armah; Janet P Tate; Vincent C Marconi; John R Koethe; Roger J Bedimo; Adeel A Butt; Cynthia L Gibert; Matthew B Goetz; Maria C Rodriguez-Barradas; Julie A Womack; Mariana Gerschenson; Vincent Lo Re; David Rimland; Michael T Yin; David Leaf; Russell P Tracy; Amy C Justice; Matthew S Freiberg Journal: J Acquir Immune Defic Syndr Date: 2017-08-15 Impact factor: 3.731
Authors: S S Martinez; A Campa; H Bussmann; S Moyo; J Makhema; F G Huffman; O D Williams; M Essex; R Marlink; M K Baum Journal: Br J Nutr Date: 2016-04-18 Impact factor: 3.718
Authors: Damalie Nakanjako; Agnes N Kiragga; Beverly S Musick; Constantin T Yiannoutsos; Kara Wools-Kaloustian; Lameck Diero; Patrick Oyaro; Emanuel Lugina; John C Ssali; Andrew Kambugu; Philippa Easterbrook Journal: AIDS Date: 2016-07-31 Impact factor: 4.177
Authors: John R Koethe; Cathy A Jenkins; Bryan Lau; Bryan E Shepherd; William Wester; Peter F Rebeiro; Michael J Silverberg; Jennifer E Thorne; John Gill; Angel M Mayor; Amanda Willig; Ronald Bosch; Michael A Horberg; Amy C Justice; Timothy R Sterling; Richard D Moore Journal: J Acquir Immune Defic Syndr Date: 2016-10-01 Impact factor: 3.731
Authors: Julie B Dumond; Camden P Bay; Julie A E Nelson; Angel Davalos; Andrew Edmonds; Kristina De Paris; Craig Sykes; Kathryn Anastos; Roopali Sharma; Seble Kassaye; Bani Tamraz; Audrey L French; Stephen Gange; Ighovwerha Ofotokun; Margaret A Fischl; David E Vance; Adaora A Adimora Journal: Antimicrob Agents Chemother Date: 2020-08-20 Impact factor: 5.191